Article Text

Download PDFPDF
Republished: DPP-4 inhibitor (sitagliptin)-induced seronegative rheumatoid arthritis

Statistics from Altmetric.com

Footnotes

  • Contributors Supervised by MK. Patient was under the care of MK. Report was written by SP and ER and was edited by MDB.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent for publication Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.